Sabatier, R., Vicier, C., Garnier, S., Guille, A., Carbuccia, N., Isambert, N., . . . Goncalves, A. (2022). Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: Plasma analysis of the TAKTIC phase IB/II study. Wiley.
Цитирование в стиле Чикаго (17-е изд.)Sabatier, Renaud, et al. Circulating Tumor DNA Predicts Efficacy of a Dual AKT/p70S6K Inhibitor (LY2780301) Plus Paclitaxel in Metastatic Breast Cancer: Plasma Analysis of the TAKTIC Phase IB/II Study. Wiley, 2022.
Цитирование MLA (9-е изд.)Sabatier, Renaud, et al. Circulating Tumor DNA Predicts Efficacy of a Dual AKT/p70S6K Inhibitor (LY2780301) Plus Paclitaxel in Metastatic Breast Cancer: Plasma Analysis of the TAKTIC Phase IB/II Study. Wiley, 2022.